These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7443421)

  • 1. [Acquired coagulation inhibitors. 10 cases (author's transl)].
    Alexandre P; André E; Briquel ME; Labrude P; Streiff F
    Nouv Presse Med; 1980 Oct; 9(39):2901-4. PubMed ID: 7443421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Circulating anticoagulants with antiprothrombinase activity in systemic lupus erythematosus (author's transl)].
    Gazengel C; Dougados M; Kremp O; Tron F; Noël LH; Jungers P
    Nouv Presse Med; 1980 Sep; 9(33):2325-8. PubMed ID: 7433022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulating anticoagulant against factor XII in a patient with autoimmune hemolitic anemia (author's transl)].
    Geroldi D; Grignani G; Montani N; Perotti G; Gamba G
    Haematologica; 1982 Feb; 67(1):52-7. PubMed ID: 6800904
    [No Abstract]   [Full Text] [Related]  

  • 4. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane autoantibodies in systemic lupus erythematosus: a case of autoimmune hemolytic anemia, antiphospholipid antibodies, and transient acquired activated protein C resistance.
    Staropoli JF; Van Cott EM; Makar RS
    Transfusion; 2008 Nov; 48(11):2435-41. PubMed ID: 18673345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus anticoagulant in Thai systemic lupus erythematosus patients.
    Intragumtornchai T; Akkawat B; Mahasandana S; Watananukul P; Deesomchok U
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():241-5. PubMed ID: 7886586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
    Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
    Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Occurrence of lupus-type circulating anticoagulant in syphilis (author's transl)].
    Guillaume JC; Gouault-Heilmann M; Dumont MD; Touraine R
    Ann Dermatol Venereol; 1981; 108(2):139-43. PubMed ID: 7247216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiphospholipid antibodies in systemic lupus erythematosus: study of a caseload of 120 patients].
    Magarò M; Zoli A; Galossi A; Caricchio R; Mirone L; Scuderi F; Altomonte L
    Ann Ital Med Int; 1994; 9(4):231-5. PubMed ID: 7893573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Venous thrombosis, circulating anticoagulant and systemic lupus erythematosus. Two cases reported in two identical HLA sisters (author's transl)].
    Perraudin ML; Rousseau A; Desbois JC; Herrault A; Léveque B
    Sem Hop; 1981 Dec 8-15; 57(45-46):1913-9. PubMed ID: 6275528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticoagulants with antithrombinase activity in systemic lupus erythematosus (author's transl)].
    Jungers P; Dougados M; Ganzegel C; Kremp O; Jacques C; Noel LH; Josso F
    Nephrologie; 1980; 1(2):67-8. PubMed ID: 7301023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
    Ames PR; Pyke S; Iannaccone L; Brancaccio V
    Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on a circulating anticoagulant in procainamide-induced lupus erythematosus.
    Edwards RL; Rick ME; Wakem CJ
    Arch Intern Med; 1981 Nov; 141(12):1688-90. PubMed ID: 6171218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Caval thromboses and systemic diseases].
    Fassin D; Wechsler B; Herson S; Godeau P
    Ann Med Interne (Paris); 1986; 137(6):456-60. PubMed ID: 3813279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thromboembolic manifestations in systemic lupus erythematosus (author's transl)].
    Jungers P; Dougados M; Gazengel C; Tron F; Bach JF
    Ann Med Interne (Paris); 1980; 131(7):416-21. PubMed ID: 7224449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
    Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiprothrombinase type of circulating anticoagulants during acute disseminated lupus erythematosus].
    Mauduit G; Souteyrand P; Thivolet J
    Ann Dermatol Venereol; 1982; 109(6-7):557-64. PubMed ID: 6985316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on circulating anticoagulant detected in a child case of male SLE (author's transl)].
    Tonooka T; Sato T
    Rinsho Ketsueki; 1977 Jul; 18(7):894-900. PubMed ID: 916218
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
    Swadźba J; Musiał J; Jankowski M; Grzywacz M; Szczeklik A
    Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.